查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1866371

全球快速診斷試劑盒市場－2025-2030年預測

Global Rapid Diagnostic Kits Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球快速診斷試劑盒市場預計將從 2025 年的 254.7 億美元成長到 2030 年的 360.83 億美元，複合年成長率為 7.22%。

快速診斷試劑盒能夠快速提供初步的醫療結果，從而以最少的資源實現及時治療。這些試劑盒設計簡便，即使是醫學知識有限的人也能輕鬆使用，對於疾病的早期發現至關重要。心血管疾病（CVD）和糖尿病等慢性疾病的日益流行，以及人們對早期療育意識的不斷提高，推動了市場的發展。技術進步提高了試劑盒的可用性和功能，促進了市場成長。然而，結果不準確、需要顯微鏡檢查才能確診以及一次性試紙等耗材的高昂成本等限制因素，限制了市場擴張。

市場促進因素

慢性病發生率呈上升趨勢

心血管疾病和糖尿病發病率的不斷上升顯著推動了對快速診斷試劑盒，尤其是心血管代謝檢測套組的需求。心血管疾病仍然是全球主要的死亡原因之一，而心臟病和中風通常可以透過早期發現來預防。糖尿病是另一個主要的健康問題，需要定期監測，這推動了對血糖監測試劑盒的需求。高血壓和高血脂症等相關疾病的快速成長進一步推動了對能夠及時干預的診斷工具的需求，從而促進了市場成長。

提高對預防性護理的認知和獲得預防性護理的機會

預防保健意識的日益增強，尤其是在已開發地區，正推動快速診斷試劑盒的普及。這些試劑盒滿足了注重健康的消費者對便利快速血糖值監測、藥物使用檢測等解決方案的需求。妊娠測試和藥物濫用檢測套組的日益普及也透過提供快速檢測結果促進了市場擴張。然而，家用檢測套組和虛擬報告服務等競爭性診斷解決方案的存在，為市場帶來了挑戰，限制了快速診斷試劑盒的應用範圍。

市場限制

快速診斷試劑盒的準確性是其主要阻礙因素。假陽性或假陰性結果需要顯微鏡檢查確認，這降低了其自身的可靠性。耗材（例如血糖值試紙）的高成本和電池容量限制也推高了營運成本，尤其是在中低收入地區，這些地區的民眾對相關知識的認知度和購買力都較低。此外，其他診斷技術的進步，提供了更準確、更全面的解決方案，進一步限制了其市場前景。

市場區隔分析

依應用領域分類，該市場可細分為血糖監測、心血管代謝檢測、傳染病檢查、藥物濫用檢測、不孕症及懷孕檢測等。由於心血管疾病 (CVD) 和糖尿病的盛行率不斷上升，預計心血管代謝檢測套組將顯著成長。血糖監測儀是糖尿病管理的必備設備，而藥物濫用檢測套組和妊娠檢測套組則因其易用性和快速出結果而備受關注。依通路，該市場涵蓋多種管道，便利的獲取途徑正在推動各細分市場的普及。

區域展望

北美預計將引領快速診斷試劑盒市場，這主要得益於該地區疾病高發、醫療基礎設施完善以及廣泛的宣傳活動。美國心臟協會 (AHA) 和美國醫學會 (AMA) 等機構正在積極推廣預防性醫療保健，推動了試劑盒的普及。同時，亞太地區預計將迎來最高的成長率，這主要受心血管疾病 (CVD)、糖尿病和癌症等非傳染性疾病 (NCD) 發病率上升的推動。政府加大醫療保健投入和意識提升的提高將促進市場擴張，但部分地區的高成本和低普及率仍然是挑戰。

由於慢性病發病率上升以及對便捷易用的診斷工具的需求不斷成長，快速診斷試劑盒市場預計將持續成長。心血管代謝疾病和血糖監測試劑盒因其在疾病管理中的重要性而佔據主導地位。北美將佔據最大的市場佔有率，而亞太地區預計將快速成長。儘管技術不斷進步，但準確性問題、高成本以及其他診斷方法的競爭限制了其發展潛力。產業相關人員需要努力提高試劑盒的可靠性和降低成本，以掌握全球健康趨勢帶來的機會。

本報告的主要優勢：

  • 深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
  • 競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略實現市場滲透的潛力。
  • 市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
  • 可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
  • 受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

  • 歷史資料（2022-2024 年）和預測資料（2025-2030 年）
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭對手定位、策略和市場佔有率分析
  • 按業務板塊和地區（國家）分類的收入成長和預測分析
  • 公司概況（策略、產品、財務資訊、關鍵趨勢等）

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 分析範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策和法規
  • 策略建議

第4章 技術展望

5. 全球快速診斷試劑盒市場（依技術分類）

  • 介紹
  • 橫向流動化驗
  • 凝血法
  • 其他

6. 全球快速診斷試劑盒市場（按應用分類）

  • 介紹
  • 血糖監測
  • 心血管代謝檢測
  • 傳染病檢查
  • 藥物濫用檢測
  • 不孕症治療和妊娠測試
  • 其他

7. 全球快速診斷試劑盒市場（依最終用戶分類）

  • 介紹
  • 醫院和診所
  • 診斷中心
  • 其他

8. 全球快速診斷試劑盒市場（按地區分類）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 台灣
    • 其他

第9章：競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 企業合併、協議、商業合作
  • 競爭對手儀錶板

第10章：公司簡介

  • Creative Diagnostics
  • Abbott Laboratories
  • NanoRepro AG
  • Atlas Medical UK
  • Coris BioConcept
  • Roche Diagnostics
  • SD Biosensor
  • ACON Laboratories Inc.
  • Alfa Scientific Designs Inc.
  • AdvaCare Pharma

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 分析方法
  • 簡稱
簡介目錄
Product Code: KSI061612022

The Global Rapid Diagnostic Kits Market is set to expand from USD 25.470 billion in 2025 to USD 36.083 billion by 2030, at a CAGR of 7.22%.

Rapid diagnostic kits deliver quick, preliminary medical results, enabling timely treatment with minimal resources. Designed for ease of use by individuals with limited medical expertise, these kits are vital for early disease detection. The market is driven by the rising prevalence of chronic diseases like cardiovascular diseases (CVD) and diabetes, coupled with growing awareness of early intervention. Technological advancements enhance kit accessibility and functionality, fostering market growth. However, limitations such as inaccurate results, the need for confirmatory microscopic tests, and high recurring costs of consumables like disposable strips restrain expansion.

Market Drivers

Rising Prevalence of Chronic Diseases

The increasing incidence of cardiovascular diseases and diabetes significantly propels the demand for rapid diagnostic kits, particularly cardiometabolic testing kits. CVD remains a leading global cause of mortality, with heart attacks and strokes often preventable through early detection. Diabetes, another major health concern, necessitates regular monitoring, boosting the demand for glucose monitoring kits. The surge in related conditions like hypertension and hyperlipidemia further drives the need for diagnostic tools to facilitate timely interventions, supporting market growth.

Growing Awareness and Accessibility

Increased awareness of preventive healthcare, especially in developed regions, encourages the adoption of rapid diagnostic kits. These kits cater to health-conscious consumers seeking convenient, fast solutions for monitoring conditions like blood glucose or drug use. The accessibility of kits for pregnancy and drug-of-abuse testing, offering quick results, also contributes to market expansion. However, the market faces challenges from competing diagnostic solutions, such as home testing and virtual reporting services, which limit the scope of rapid kits.

Market Restraints

The accuracy of rapid diagnostic kits is a significant limitation, as false-positive or false-negative results necessitate confirmatory microscopic tests, reducing their standalone reliability. High costs of consumables, such as glucose monitor strips, and battery limitations add to operational expenses, particularly in low- and middle-income regions where awareness and affordability are lower. Advancements in alternative diagnostic technologies further constrain market prospects by offering more precise or comprehensive solutions.

Market Segment Analysis

The market is segmented by application into glucose monitoring, cardiometabolic testing, infectious disease testing, drug-of-abuse testing, fertility and pregnancy testing, and others. Cardiometabolic testing kits are expected to grow significantly due to the rising prevalence of CVD and diabetes. Glucose monitors are critical for diabetes management, while drug-of-abuse and pregnancy testing kits gain traction due to their ease of use and rapid results. By distribution, the market includes various channels, with accessibility driving adoption across segments.

Geographical Outlook

North America is poised to dominate the rapid diagnostic kits market, driven by high disease prevalence, robust healthcare infrastructure, and widespread awareness campaigns. Organizations like the American Heart Association (AHA) and American Medical Association (AMA) promote preventive health measures, boosting kit adoption. The Asia-Pacific region, however, is projected to grow at the fastest rate, fueled by the rising burden of non-communicable diseases (NCDs) like CVD, diabetes, and cancer. Increasing government healthcare investments and growing awareness support market expansion, though high costs and lower adoption rates in some areas pose challenges.

The rapid diagnostic kits market is set for growth, driven by the rising incidence of chronic diseases and increasing demand for accessible, user-friendly diagnostic tools. Cardiometabolic and glucose monitoring kits lead due to their relevance in managing prevalent conditions. North America holds the largest market share, while Asia-Pacific promises rapid growth. Despite technological advancements, accuracy issues, high costs, and competition from alternative diagnostics limit potential. Industry stakeholders must focus on improving kit reliability and affordability to capitalize on global health trends.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Market Segmentation:

By Technology

  • Lateral Flow Assay
  • Agglutination
  • Others

By Application

  • Glucose Monitoring
  • Cardiometabolic Testing
  • Infectious Disease Testing
  • Drugs-of-Abuse Testing
  • Fertility & Pregnancy Testing
  • Others

By End-User

  • Hospitals & Clinics
  • Diagnostics Centers
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL RAPID DIAGNOSTIC KITS MARKET BY TECHNOLOGY

  • 5.1. Introduction
  • 5.2. Lateral Flow Assay
  • 5.3. Agglutination
  • 5.4. Others

6. GLOBAL RAPID DIAGNOSTIC KITS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Glucose Monitoring
  • 6.3. Cardiometabolic Testing
  • 6.4. Infectious Disease Testing
  • 6.5. Drugs-ON-Abuse Testing
  • 6.6. Fertility & Pregnancy Testing
  • 6.7. Others

7. GLOBAL RAPID DIAGNOSTIC KITS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals & Clinics
  • 7.3. Diagnostics Centers
  • 7.4. Others

8. GLOBAL RAPID DIAGNOSTIC KITS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Taiwan
    • 8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Creative Diagnostics
  • 10.2. Abbott Laboratories
  • 10.3. NanoRepro AG
  • 10.4. Atlas Medical UK
  • 10.5. Coris BioConcept
  • 10.6. Roche Diagnostics
  • 10.7. SD Biosensor
  • 10.8. ACON Laboratories Inc.
  • 10.9. Alfa Scientific Designs Inc.
  • 10.10. AdvaCare Pharma

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations